Godrej Agrovet Limited reported a 17% year-on-year increase in revenue to ₹2,995 crore for the second quarter of FY27, supported by growth across its Animal Nutrition, Oil Palm and B2C Foods businesses. Higher realisations and volumes contributed to the performance amid a challenging operating environment.
The company’s EBITDA for the quarter stood at ₹222 crore, broadly flat compared with the year-ago period. Operating margins declined by approximately 120 basis points, reflecting input cost inflation and challenges associated with El Niño conditions. Profit before tax increased 5% to ₹131 crore, while profit after tax rose 22% to ₹103 crore.
Godrej Agrovet also strengthened its working capital position during the quarter. Its working capital cycle improved to 21 days, equivalent to approximately ₹655 crore, compared with 32 days and around ₹894 crore in Q2 FY26. For the first half of FY27, revenue grew 13% to ₹5,847 crore. Growth was led by the Oil Palm and Animal Nutrition businesses, with additional contributions from Dairy and Foods. However, EBITDA declined 5%, PBT fell 4% and PAT was down 1% year on year.
Sunil Kataria, Chief Executive Officer and Managing Director, Godrej Agrovet Limited, said the company delivered a resilient performance despite weather-related disruptions, geopolitical volatility and inflationary pressures. He highlighted that Animal Nutrition and Oil Palm recorded Q2 revenue growth of 14% and 28%, respectively. Animal Nutrition segment profit increased 32%, supported by improved realisations, product mix and operational efficiencies.
Crop Care revenue grew 42% against a low base, although El Niño-related conditions affected profitability. Astec’s revenue declined approximately 3%, as 15% growth in its contract development and manufacturing organisation (CDMO) business was offset by weaker enterprise demand. Dairy revenue increased 6%, supported by calibrated pricing and value-added products, while Foods recorded 8% growth, led by its B2C portfolio. The Bangladesh joint venture, ACI-GAVL, registered 32% revenue growth, supported by a 21% increase in volumes.
The company continued to advance its strategic transformation across businesses. Animal Nutrition is focusing on premiumisation and has exited the shrimp business to concentrate on more profitable and scalable segments. Oil Palm is expanding its plantation footprint and progressing with the commissioning of its Khammam complex, CPKO refinery and biogas plant.
In Crop Care, H1 sales of Ashitaka® were six times the level recorded in the previous year. Foods increased B2C contribution to approximately 38% of its portfolio from 27%, with growth of around 50%. Dairy’s value-added products contributed approximately 49% of its portfolio, compared with 44% earlier, alongside calibrated pricing and a go-to-market pilot. Astec continues to focus on CDMO opportunities, new products and improved capacity utilisation. Mr Kataria said the company’s diversified agriculture and food platform, together with its focus on operational improvements and strategic priorities, positions it to pursue sustainable long-term value creation.
Godrej Agrovet Limited (GAVL) is a diversified, R&D-driven food and agribusiness company dedicated to improving Indian farmers’ productivity through innovative and sustainable solutions. Its businesses span Animal Feed, Crop Protection, Oil Palm, Dairy, Poultry, and Processed Foods, with leading market positions across segments. GAVL also operates through subsidiaries including Astec Lifesciences, Creamline Dairy Products, and Godrej Foods, alongside a joint venture with Bangladesh’s ACI Group in animal feed.